Critical Reviews™ in Oncogenesis

ISSN for PRINT: 0893-9675

For Online Access

Best Paper Award Selection - Editorial Board Site

2006, Volume12

Jeroen de Jong
Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Daniel den Hoed, Rotterdam, The Netherlands

Leendert H. J. Looijenga
Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Room 430b, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands

The transcription factor OCT3/4 (also known as POU5F1 and Oct4) is regarded as one of the key regulators of pluripotency. Expression in nonmalignant cells is restricted to the pluripotent cells in the embryo and the primordial germ cells that will pass pluripotency to future generations via the gametes. Although major progress has been made in successfully identifying other players in the pluripotency network by using high-throughput screening methods, the exact mechanisms involved in regulation of OCT3/4 in vivo remain largely to be elucidated. In human tumors, OCT3/4 is the most informative marker in germ cell tumors diagnostics and is expressed in the precursor lesions gonadoblastoma and carcinoma in situ, as well as in invasive embryonal carcinoma and seminomatous tumors. Currently, the application of OCT3/4 for screening in high-risk patient populations is the novel focus of study. This article reviews OCT3/4 expression in normal development and germ cell tumors. In addition, expression in adult tissues and nongerm cell tumor malignancies in relation to splice variants and pseudogenes is discussed. An overview of the upstream and downstream factors in the OCT3/4 pathway as well as the epigenetic regulation of the gene is summarized and the possible role in oncogenesis considered.

Download article, 171-203 pages

Article price - $35.00

  Next article >>